Longeveron (LGVN) Total Debt (QoQ) (2023)

Longeveron (LGVN) Total Debt (QoQ) (2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,801.52 Bn 66,801.23 Bn -
2 Nanobiotix 1,935.05 Bn 1,934.98 Bn -
3 Akari Therapeutics 1,021.31 Bn 1,021.31 Bn -
4 BeOne Medicines 467.89 Bn 463.10 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.95 Bn 115.70 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.19 Bn 61.44 Bn 3.31 Bn
7 Belite Bio 63.46 Bn 63.46 Bn -
8 Argenx Se 55.64 Bn 50.45 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.67 Bn 34.66 Bn 959.66 Mn
10 Longeveron 15.11 Bn 15.10 Bn 264,000.00

Historic Data

Download Data
DateValue
Sep 30, 2023 1.38%
Jun 30, 2023 1.23%
Mar 31, 2023 1.24%